ATE469119T1 - Verfahren zur herstellung von polymorphen von sertralin hydrochlorid - Google Patents

Verfahren zur herstellung von polymorphen von sertralin hydrochlorid

Info

Publication number: ATE469119T1
Authority: AT; Austria
Prior art keywords: polymorphoes; producing; sertraline hydrochloride; sertraline; hydrochloride
Prior art date: 2003-11-04

Application number

AT04798397T

Other languages

English (en)

Inventor

Dharmaraj Rao

Rajendra Kankan

Original Assignee

Cipla Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-11-04

Filing date

2004-11-04

Publication date

2010-06-15

2004-11-04 Application filed by Cipla Ltd filed Critical Cipla Ltd

2010-06-15 Application granted granted Critical

2010-06-15 Publication of ATE469119T1 publication Critical patent/ATE469119T1/de

Links

GLQPTZAAUROJMO-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)benzaldehyde Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC=C(C=O)C=C1 GLQPTZAAUROJMO-UHFFFAOYSA-N 0.000 title abstract 3
229960003660 sertraline hydrochloride Drugs 0.000 title abstract 3
238000004519 manufacturing process Methods 0.000 title 1
229960002073 sertraline Drugs 0.000 abstract 2
VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 abstract 2
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/82—Purification; Separation; Stabilisation; Use of additives
- C07C209/84—Purification
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
- C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
- C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT04798397T 2003-11-04 2004-11-04 Verfahren zur herstellung von polymorphen von sertralin hydrochlorid ATE469119T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IN1158MU2003		2003-11-04
PCT/GB2004/004672 WO2005047229A2 (en)	2003-11-04	2004-11-04	Process for the preparation of polymorphs of selective serotonin reuptake inhibitor

Publications (1)

Publication Number	Publication Date
ATE469119T1 true ATE469119T1 (de)	2010-06-15

Family

ID=34586963

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04798397T ATE469119T1 (de)	2003-11-04	2004-11-04	Verfahren zur herstellung von polymorphen von sertralin hydrochlorid

Country Status (13)

Country	Link
US (1)	US7893300B2 (de)
EP (1)	EP1682483B1 (de)
JP (1)	JP4791970B2 (de)
KR (1)	KR101161813B1 (de)
CN (1)	CN1902157A (de)
AT (1)	ATE469119T1 (de)
AU (1)	AU2004289512A1 (de)
CA (1)	CA2544684A1 (de)
DE (1)	DE602004027401D1 (de)
NZ (1)	NZ546902A (de)
RU (1)	RU2376279C2 (de)
WO (1)	WO2005047229A2 (de)
ZA (1)	ZA200603502B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2014197242A1 (en) *	2013-06-04	2014-12-11	Dow Global Technologies Llc	Process for manufacturing lithium carboxymethyl cellulose
CN112552188B (zh) *	2020-12-17	2023-07-28	山西仟源医药集团股份有限公司	盐酸舍曲林晶型i的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4536518A (en)	1979-11-01	1985-08-20	Pfizer Inc.	Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US5082970A (en) *	1991-03-06	1992-01-21	Pfizer Inc.	Process for recycling amine isomer
US5248699A (en) *	1992-08-13	1993-09-28	Pfizer Inc.	Sertraline polymorph
US5734083A (en)	1996-05-17	1998-03-31	Torcan Chemical Ltd.	Sertraline polymorph
IL133080A0 (en) *	1997-07-01	2001-03-19	Pfizer	Sertraline salts and sustained-release dosage forms of sertraline
US6500987B1 (en) *	1998-11-27	2002-12-31	Teva Pharmaceutical Industries Ltd.	Sertraline hydrochloride polymorphs
US6495721B1 (en)	1999-08-09	2002-12-17	Teva Pharmaceutical Industries Ltd.	Sertraline hydrochloride Form II and methods for the preparation thereof
TWI260315B (en) *	1999-10-29	2006-08-21	Ciba Sc Holding Ag	Polymorphic forms of sertraline hydrochloride
YU47902A (sh)	1999-12-21	2005-11-28	Teva Pharmaceutical Industries Ltd.	Novi polimorfi sertralin hidrohlorida, postupci za njihovo dobijanje, preparati koji ih sadrže i postupci za njihovu upotrebu
EP1499581A1 (de) *	2002-04-29	2005-01-26	Teva Pharmaceutical Industries Ltd.	Verfahren zur herstellung der polymorphen form ii von sertralinhydrochlorid, pharmazeutische formulierungen und verfahren zur deren verabreichung

2004
- 2004-11-04 CA CA002544684A patent/CA2544684A1/en not_active Abandoned
- 2004-11-04 CN CNA2004800397985A patent/CN1902157A/zh active Pending
- 2004-11-04 US US10/577,714 patent/US7893300B2/en not_active Expired - Fee Related
- 2004-11-04 AT AT04798397T patent/ATE469119T1/de not_active IP Right Cessation
- 2004-11-04 DE DE602004027401T patent/DE602004027401D1/de not_active Expired - Lifetime
- 2004-11-04 RU RU2006119477/04A patent/RU2376279C2/ru not_active IP Right Cessation
- 2004-11-04 WO PCT/GB2004/004672 patent/WO2005047229A2/en not_active Ceased
- 2004-11-04 EP EP04798397A patent/EP1682483B1/de not_active Expired - Lifetime
- 2004-11-04 JP JP2006537441A patent/JP4791970B2/ja not_active Expired - Fee Related
- 2004-11-04 KR KR1020067010735A patent/KR101161813B1/ko not_active Expired - Fee Related
- 2004-11-04 NZ NZ546902A patent/NZ546902A/en not_active IP Right Cessation
- 2004-11-04 ZA ZA200603502A patent/ZA200603502B/en unknown
- 2004-11-04 AU AU2004289512A patent/AU2004289512A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1682483B1 (de)	2010-05-26
NZ546902A (en)	2010-02-26
US20070135524A1 (en)	2007-06-14
AU2004289512A1 (en)	2005-05-26
JP2007510640A (ja)	2007-04-26
AU2004289512A2 (en)	2005-05-26
WO2005047229A2 (en)	2005-05-26
KR101161813B1 (ko)	2012-07-05
CA2544684A1 (en)	2005-05-26
JP4791970B2 (ja)	2011-10-12
EP1682483A2 (de)	2006-07-26
WO2005047229A3 (en)	2005-07-07
DE602004027401D1 (de)	2010-07-08
ZA200603502B (en)	2008-02-27
RU2376279C2 (ru)	2009-12-20
KR20060123234A (ko)	2006-12-01
CN1902157A (zh)	2007-01-24
RU2006119477A (ru)	2007-12-20
US7893300B2 (en)	2011-02-22

Similar Documents

Publication	Publication Date	Title
ATE425136T1 (de)	2009-03-15	Verfahren zur herstellung substituierter 3-aryl- butyl-aminverbindungen
ATE529409T1 (de)	2011-11-15	Verfahren zur herstellung von kristallinen aripiprazolformen
DE60228118D1 (de)	2008-09-18	Verfahren zur herstellung von o-desmethylvenlafaxin
ATE501264T1 (de)	2011-03-15	Enzymatische verfahren zur herstellung 4- substituierter 3-hydroxybuttersäure-derivate
DE60320527D1 (de)	2008-06-05	Verfahren zur herstellung von grünteepolyphenol
ATE482966T1 (de)	2010-10-15	Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
ATE444950T1 (de)	2009-10-15	Verfahren zur herstellung von 1-amino-3,5- dimethyladamantan-hydrochlorid
ATE354583T1 (de)	2007-03-15	Verfahren zur herstellung c-7 substituierter 5- androstene
DE602005014280D1 (de)	2009-06-10	Verfahren zur herstellung von ä1,4,5ü-oxadiazepinderivaten
DE60239286D1 (de)	2011-04-07	Verfahren zur herstellung von trans-1,4-cyclohexandicarbonsäure
ATE424892T1 (de)	2009-03-15	Verfahren zur herstellung von derivaten des 4a,5, 9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins
DE60300144D1 (de)	2004-12-16	Verfahren zur Herstellung von Al-Sinterlegierung
DE60210778D1 (de)	2006-05-24	Verfahren zur herstellung von 4-amino-2,5-bisheterocyclylchinazolinen
DE60309847D1 (de)	2007-01-04	Zwischenprodukte und verfahren zur herstellung von heptapeptid-oxytocinanaloga
DE60113157T2 (de)	2006-06-14	Verbessertes verfahren zur herstellung von simvastatin
ATE542810T1 (de)	2012-02-15	Verfahren zur herstellung von 3,5-di-omikron-acyl-2-fluor-2-c-methyl-d-ribono gamma-lacton
ATE281434T1 (de)	2004-11-15	Verfahren zur herstellung von benzoperhydroisoindolen
DE50211253D1 (de)	2008-01-03	Verfahren zur Herstellung von Makrokapseln
ATE496038T1 (de)	2011-02-15	Verfahren zur herstellung von quetiapin
ATE325794T1 (de)	2006-06-15	Verfahren zur herstellung und zwischenprodukte von pyridin-2-yl-amin
DE602004001646D1 (de)	2006-09-07	Verfahren zur Herstellung von Pyran
DE50205026D1 (de)	2005-12-29	Verfahren zur herstellung von n-substituierten 2,6-dialkylmorpholinen
DE602004027401D1 (de)	2010-07-08	Verfahren zur herstellung von polymorphen von sertralin hydrochlorid
ATE282594T1 (de)	2004-12-15	Verfahren zur herstellung von (+)-trans-4-p- fluorophenyl-3-hydroxymethyl-1-methylpiperidin
DE602004008486D1 (de)	2007-10-04	Verfahren zur herstellung von (1s,4r)-cis-4-ä2-amino-6-chlor-9h-purin-9-ylü-2-cyclopenten-1-methanol

Legal Events

Date	Code	Title	Description
2010-11-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties